(Q68638086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

title

Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

0 references

1 reference

G H McCracken

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

J P Luby

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

language of work or name

English

0 references

publication date

1 March 1972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

26 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

488-493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

Congenital cytomegalic inclusion disease. A longitudinal study of 20 patients

26 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

Congenital and acquired cytomegalovirus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

Congenital cytomegalovirus infection treated with idoxuridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

Severe generalized primary herpes treated with cytarabine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

Disseminated varicella in a patient with acute myelogenous leukemia: treatment with cytosine arabinoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

Clinical pharmacology and human antitumor activity of cytosine arabinoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

Immune competence in congenital rubella: Lymphocyte transformation, delayed hypersensitivity, and response to vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2872%2980515-8

10.1016/S0022-3476(72)80515-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4334178%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference